Literature DB >> 2614846

Tertiary structure of bacteriorhodopsin. Positions and orientations of helices A and B in the structural map determined by neutron diffraction.

J L Popot1, D M Engelman, O Gurel, G Zaccaï.   

Abstract

Positions and rotations of two helices in the tertiary structure of bacteriorhodopsin have been studied by neutron diffraction using reconstituted, hybrid purple membrane samples. Purple membrane was biosynthetically 2H-labeled at non-exchangeable hydrogen positions of leucine and tryptophan residues. Two chymotryptic fragments were purified, encompassing either the first two or the last five of the seven putative transmembrane segments identified in the amino acid sequence of bacteriorhodopsin. The 2H-labeled fragments, diluted to variable extents with the identical, unlabeled fragment, were mixed with their unlabeled counterpart; bacteriorhodopsin was then renatured and reconstituted. The crystalline purple membrane samples thus obtained contained hybrid bacteriorhodopsin molecules in which certain transmembrane segments had been selectively 2H-labeled to various degrees. Neutron diffraction powder patterns were recorded and analyzed both by calculating difference Fourier maps and by model building. The two analyses yielded consistent results. The first and second transmembrane segments in the sequence correspond to helices 1 and 7 of the three-dimensional structure, respectively. Rotational orientations of these two helices were identified using best fits to the observed diffraction intensities. The data also put restrictions on the position of the third transmembrane segment. These observations are discussed in the context of folding models for bacteriorhodopsin, the environment of the retinal Schiff base, and site-directed mutagenesis experiments.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2614846     DOI: 10.1016/0022-2836(89)90111-3

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  14 in total

Review 1.  Structural features of heterotrimeric G-protein-coupled receptors and their modulatory proteins.

Authors:  H LeVine
Journal:  Mol Neurobiol       Date:  1999-04       Impact factor: 5.590

2.  Membrane peptides and their role in protobiological evolution.

Authors:  Andrew Pohorille; Michael A Wilson; Christophe Chipot
Journal:  Orig Life Evol Biosph       Date:  2003-04       Impact factor: 1.950

3.  Imaging the membrane protein bacteriorhodopsin with the atomic force microscope.

Authors:  H J Butt; K H Downing; P K Hansma
Journal:  Biophys J       Date:  1990-12       Impact factor: 4.033

4.  An energy-based approach to packing the 7-helix bundle of bacteriorhodopsin.

Authors:  K C Chou; L Carlacci; G M Maggiora; L A Parodi; M W Schulz
Journal:  Protein Sci       Date:  1992-06       Impact factor: 6.725

5.  A molecular piston mechanism of pumping protons by bacteriorhodopsin.

Authors:  K C Chou
Journal:  Amino Acids       Date:  1994-02       Impact factor: 3.520

6.  On the distribution of amino acid residues in transmembrane alpha-helix bundles.

Authors:  F A Samatey; C Xu; J L Popot
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

7.  Thermal motions and function of bacteriorhodopsin in purple membranes: effects of temperature and hydration studied by neutron scattering.

Authors:  M Ferrand; A J Dianoux; W Petry; G Zaccaï
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

8.  Automated method for modeling seven-helix transmembrane receptors from experimental data.

Authors:  P Herzyk; R E Hubbard
Journal:  Biophys J       Date:  1995-12       Impact factor: 4.033

Review 9.  Conformational change during photocycle of bacteriorhodopsin and its proton-pumping mechanism.

Authors:  K C Chou
Journal:  J Protein Chem       Date:  1993-06

10.  Membrane topology analysis of Escherichia coli K-12 Mtr permease by alkaline phosphatase and beta-galactosidase fusions.

Authors:  J P Sarsero; A J Pittard
Journal:  J Bacteriol       Date:  1995-01       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.